Context
Between September 2020 and May 2023, Sanofi Pasteur COPEPAC (Colombia, Peru, Central America, and the Caribbean) needed to position itself as a reference in vaccines. The goal was to educate on the risk, severity, and impact of vaccine-preventable diseases in order to reinforce the value of the full portfolio: influenza, pediatric vaccines (diphtheria, tetanus, pertussis, polio, hepatitis B, and Hib), and endemic diseases such as yellow fever and dengue.